SI-BONE CEO sells shares to cover RSU taxes
SI-BONE, Inc.’s Chief Executive Officer Laura Francis reported open-market sales of 14,957 shares of common stock on May 18, 2026, at weighted average prices around the mid-$14 range.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
SI-BONE, Inc.’s Chief Executive Officer Laura Francis reported open-market sales of 14,957 shares of common stock on May 18, 2026, at weighted average prices around the mid-$14 range. According to the disclosure, these shares were sold solely to cover tax withholding obligations tied to vesting restricted stock units and were not discretionary trades.
Following the sales, Francis directly holds 503,444 shares of SI-BONE common stock. She also has indirect ownership of additional shares held by a family trust, providing substantial ongoing equity exposure despite the tax-related share sales.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 3,893 | $14.7453 | $57K |
| Sale | Common Stock | 2,236 | $14.6749 | $33K |
| Sale | Common Stock | 1,973 | $14.5694 | $29K |
| Sale | Common Stock | 3,652 | $14.7499 | $54K |
| Sale | Common Stock | 3,203 | $14.7273 | $47K |
| holding | Common Stock | -- | -- | -- |
Footnotes (9)
- F1. The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.
- F2. This transaction was executed in multiple trades at prices ranging from $14.34 USD to $14.84 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F3. This transaction was executed in multiple trades at prices ranging from $14.35 USD to $14.85 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F4. This transaction was executed in multiple trades at prices ranging from $14.34 USD to $14.87 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F5. This transaction was executed in multiple trades at prices ranging from $14.33 USD to $14.85 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F6. Includes 1,395 shares acquired under the SI-BONE, Inc 2018 Employee Stock Purchase Plan on May 15, 2026.
- F7. Reflects the transfer of shares from the Reporting Person to The David & Laura Joint Rev Tr.
- F8. Includes 385,070 shares issuable on the settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
- F9. Shares held by The David & Laura Joint Rev Tr.
Key Figures
Key Terms
restricted stock units financial
sell to cover financial
weighted average sale price financial
Employee Stock Purchase Plan financial
trust financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did SI-BONE (SIBN) CEO Laura Francis report?
What does the SI-BONE (SIBN) Form 4 say about Laura Francis’s trust holdings?
Does the SI-BONE (SIBN) Form 4 mention restricted stock units for Laura Francis?
AI-generated analysis. How Rhea-AI works. Not financial advice.